Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020
Period Ending	Nov 4, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	822	113	35	44	113	38
Market Cap Growth	259.26%	221.19%	-19.99%	-61.12%	200.36%	36.12%
Enterprise Value	533	98	-19	-14	49	36
Last Close Price	12.19	4.02	2.47	3.09	7.98	5.55
PE Ratio	-	-2.31	-3.26	-6.03	-24.44	-10.86
PS Ratio	459.21	78.65	6.48	-	11.23	3.88
PB Ratio	2.41	1.50	0.64	0.72	1.67	6.57
P/FCF Ratio	-27.36	-2.97	-3.29	-5.50	-35.08	-9.60
P/OCF Ratio	-47.44	-3.06	-3.38	-5.69	-39.79	-10.32
EV/Sales Ratio	364.04	68.42	-3.42	-	4.86	3.74
EV/EBITDA Ratio	-10.46	-2.46	2.19	2.35	-15.14	-11.08
EV/EBIT Ratio	-10.15	-2.40	2.11	2.25	-14.22	-10.42
EV/FCF Ratio	-20.12	-2.58	1.74	1.81	-15.19	-9.26
Debt / Equity Ratio	0.01	0.03	-	0.01	0.01	0.18
Debt / FCF Ratio	-0.16	-0.07	-	-0.07	-0.24	-0.26
Asset Turnover	0.01	0.02	-	-	0.25	1.07
Inventory Turnover	-	-	-	-	6.07	7.75
Quick Ratio	27.62	0.66	14.47	25.38	36.58	2.84
Current Ratio	27.73	1.07	17.07	26.18	37.37	3.50
Return on Equity (ROE)	-23.20%	-57.70%	-	-9.79%	-9.26%	-51.42%
Return on Assets (ROA)	-12.03%	-32.81%	-	-5.95%	-5.43%	-23.98%
Return on Capital (ROIC)	-13.35%	-38.66%	-	-6.17%	-5.74%	-30.16%
Earnings Yield	-7.18%	-41.23%	-30.64%	-16.57%	-3.00%	-9.17%
FCF Yield	-2.99%	-33.68%	-30.42%	-18.17%	-2.85%	-10.42%
Buyback Yield / Dilution	-117.29%	-88.39%	-0.06%	-36.74%	-53.61%	-0.83%
Total Shareholder Return	-117.29%	-88.39%	-0.06%	-36.74%	-53.61%	-0.83%

Source: S&P Capital IQ. Standard template. Financial Sources.